1
|
Zhao L, Zhou Y, Ding J, Qin Z, Zhou H, Jing X. Primary hepatic squamous cell carcinoma: case report and systematic review of the literature. Front Oncol 2023; 13:1229936. [PMID: 38239651 PMCID: PMC10795173 DOI: 10.3389/fonc.2023.1229936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Accepted: 09/18/2023] [Indexed: 01/22/2024] Open
Abstract
Primary hepatic squamous cell carcinoma (SCC) is extremely rare, and only a few dozen cases have been reported to date. It can barely be diagnosed before histopathological examination, which necessitates the exclusion of metastatic tumors. In this case, we present a 60-year-old female patient with no comorbidity. As laboratory tests and imaging examinations were not diagnostic, ultrasonography (US)-guided liver biopsy was performed and eventually revealed a definitive pathological diagnosis of hepatic SCC. After excluding metastasis, the diagnosis of primary hepatic SCC was established, and then chemotherapy and immunotherapy were performed. Additionally, a comprehensive literature search was conducted on primary hepatic SCC using PubMed, Google Scholar, and Web of Science, and a total of 53 articles were retrieved with a time range from 1972 to 2022. A critical analysis was then performed to evaluate previous literature focusing on the clinical characteristics, imaging features, treatments, and prognosis.
Collapse
Affiliation(s)
- Lin Zhao
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Yan Zhou
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Jianmin Ding
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Zhengyi Qin
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Hongyu Zhou
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| | - Xiang Jing
- Department of Ultrasound, The Third Central Hospital of Tianjin, Tianjin, China
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin Third Central Hospital, Tianjin, China
- Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China
| |
Collapse
|
2
|
Wang K, Lu CD, Sun JN, Wang CN, Gao G, Hu YK, Zhang HZ, Zhang D, Wu SD. Primary Hepatic Squamous Cell Carcinoma With High Microsatellite Instability Shows Good Response to Programmed Cell Death 1 Inhibitor as Adjuvant Therapy. Hepatology 2021; 74:1695-1697. [PMID: 33544903 DOI: 10.1002/hep.31737] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Revised: 01/19/2021] [Accepted: 01/29/2021] [Indexed: 12/23/2022]
Affiliation(s)
- Ke Wang
- Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Treatment Centre Li Huili Hospital, Ningbo University, Ningbo, China
| | - Cai De Lu
- Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Treatment Centre Li Huili Hospital, Ningbo University, Ningbo, China
| | - Jian Nan Sun
- Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Treatment Centre Li Huili Hospital, Ningbo University, Ningbo, China
| | - Chun Nian Wang
- Department of Pathology, Ningbo Clinical and Pathological diagnosis center, Ningbo, China
| | - Guo Gao
- Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Treatment Centre Li Huili Hospital, Ningbo University, Ningbo, China
| | - Yang Ke Hu
- Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Treatment Centre Li Huili Hospital, Ningbo University, Ningbo, China
| | - Hui Zhi Zhang
- Department of Pathology, Ningbo Clinical and Pathological diagnosis center, Ningbo, China
| | - Ding Zhang
- The Medical Department, 3D Medicines Inc., Shanghai, China
| | - Sheng Dong Wu
- Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Treatment Centre Li Huili Hospital, Ningbo University, Ningbo, China
| |
Collapse
|